William C. Olson, VP, Research & Development at PROGENICS PHARMACEUTICALS INC (PGNX), sold 2,500 shares at $4.73 ($12K) on 2009-06-23, disclosed to the SEC on 2009-06-24.
Scheduled sale ($12k) by VP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGNX | SELL | 2007-12-05 | $76K | — | Filing → |
| PGNX | SELL | 2006-06-22 | $22K | — | Filing → |
| PGNX | SELL | 2006-05-08 | $336K | — | Filing → |